Company
United StatesGlaxoSmithKline dba Human Genome Sciences Inc, Rockville, MD – FDA Inspections
Inspection records and compliance data for GlaxoSmithKline dba Human Genome Sciences Inc in Rockville, Maryland. 9 FDA inspections on record, 3 Form 483s, last inspected July 31, 2025.
Company Profile
This profile covers GlaxoSmithKline dba Human Genome Sciences Inc based in Rockville, Maryland, United States.
FDA Inspection History
- FDA inspections
- 9
- OAI
- 0
- VAI
- 1
- NAI
- 5
- Unclassified
- 3
- Form 483s
- 3
- Warning letters
- 0
First inspected July 31, 2009. Last inspected July 31, 2025.
FDA inspections (9)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 31, 2025 | Not classified | Human Drugs | 1277363 |
| December 11, 2023 | Not classified | Human Drugs | 1226290 |
| March 15, 2019 | Not classified | Human Drugs | 1108003 |
| August 30, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1068898 |
| April 11, 2016 | VAI | Human Drugs · Drug Quality Assurance | 989778 |
| November 5, 2013 | NAI | Human Drugs · Drug Quality Assurance | 854065 |
| November 2, 2012 | NAI | Human Drugs · Drug Quality Assurance | 805643 |
| September 8, 2010 | NAI | Human Drugs · Bioresearch Monitoring | 679484 |
| July 31, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 601372 |
FDA documents
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
GlaxoSmithKline dba Human Genome Sciences Inc
FEI Number
3003782237
Address
9910 Belward Campus Dr, Rockville, Maryland 20850, United States
Country
United States
ID: c3dd2e54-125d-4d56-b0dc-18cb333074cc